BLRXbenzinga

HC Wainwright & Co. Reiterates Buy on BioLine Rx, Maintains $26 Price Target

Summary

No summary available.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on May 28, 2025 by benzinga

    HC Wainwright & Co. Reiterates Buy on BioLine Rx, Maintains $26 Price Target | BLRX Stock News | Candlesense